Heidi Henson Caladrius Biosciences, Inc. (CLBS) insider trading activity

CLBS Quotes by TradingView

Heidi Henson is Director of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 85,725 shares of CLBS, which is worth approximately $301,752. The most recent transaction as insider was on Jan 09, 2026, when has been sold 30,456 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.7K
55.11% 3M change
55.11% 12M change
Total Value Held $301,752

HEIDI HENSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2026
BUY
Grant, award, or other acquisition
-
30,456 Added 26.21%
85,725 Common Stock
Jan 09 2025
BUY
Grant, award, or other acquisition
-
15,789 Added 22.22%
55,269 Common Stock
Jan 09 2024
BUY
Grant, award, or other acquisition
-
19,480 Added 33.04%
39,480 Common Stock
Jan 09 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock

Also insider at

PRDS
PARDES BIOSCIENCES, INC. Healthcare
Chief Financial Officer
PEPG
PepGen Inc. Healthcare
Director
ISR
Isoray, Inc. Healthcare
HH

Heidi Henson

Director
Carlsbad, CA

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLBS